<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04966806</url>
  </required_header>
  <id_info>
    <org_study_id>PSYoussef</org_study_id>
    <nct_id>NCT04966806</nct_id>
  </id_info>
  <brief_title>Contribution of SA and Coma to The Total Ocular HOA Before and After FS-LASIK Using An Aspheric Ablation Profile</brief_title>
  <official_title>Contribution of Spherical Aberration and Coma to The Total Ocular High Order Aberration Before and After Femtosecond Laser-Assisted in Situ Keratomileusis Using An Aspheric Ablation Profile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laser-assisted in situ keratomileusis (LASIK) is the most frequently performed refractive&#xD;
      surgery procedure for the correction of myopia, hyperopia, and astigmatism.&#xD;
&#xD;
      There is a continuous upgrade and development in LVC surgeries correlated with the evolution&#xD;
      of new machines and enhancement of the ablation profiles. One of the main undesirable effects&#xD;
      of corneal refractive surgeries using conventional ablation profiles is the increase in HOAs&#xD;
      which is associated with haloes, glare, ghost images, starburst patterns and monocular&#xD;
      diplopia, especially in low lighting conditions and during night driving.&#xD;
&#xD;
      Over the years many ablation profiles have been developed such as wavefront-guided, wavefront&#xD;
      optimized, topography guided, Q- Value based and aspheric ablation profiles. These profiles&#xD;
      aim to abolish LOAs and to prevent induction or increase of pre-existing HOAs aiming to&#xD;
      improve the quality of vision experienced post-operative.&#xD;
&#xD;
      In spite of the vast body of research in this area, there remains a gap in the literature&#xD;
      investigating higher-order aberrations' components in-depth. Therefore, this study aims to&#xD;
      investigate the contribution of spherical aberration and coma to the total higher order&#xD;
      aberration before and after femtosecond assisted laser in situ keratomileusis using an&#xD;
      aspheric ablation profile.&#xD;
&#xD;
      This current study is a Descriptive analytical study that was conducted on 34 eyes of 17&#xD;
      patients who underwent corneal refractive surgery.&#xD;
&#xD;
      The results were analyzed to compare the effect of FS-LASIK surgery on corneal coma and SA,&#xD;
      and the contribution of each of them on total ocular HOAs preoperative and post-operative.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 10, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in percentage of contribution of coma and spherical aberration from total ocular HOA before and after FS-LASIK.</measure>
    <time_frame>6 months</time_frame>
    <description>Measuring unit for coma and spherical aberrations and total ocular HOA is equivalent Diopters.&#xD;
The contribution of coma and spherical aberrations to total ocular HOA will be measured as a percentage.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">17</enrollment>
  <condition>FS-LASIK Surgery Effect on Higher Order Aberrations</condition>
  <arm_group>
    <arm_group_label>Percentage of Coma and SA to Total ocular HOA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LASIK refractive surgery</intervention_name>
    <description>laser vision correction for myopic eyes</description>
    <arm_group_label>Percentage of Coma and SA to Total ocular HOA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age: between 18 years and 45 years&#xD;
&#xD;
          2. Myopes from -1.50 D to -8.00 D&#xD;
&#xD;
          3. Astigmatism less than -4.00 D&#xD;
&#xD;
          4. Normal Corneal Tomography with a Belin Ambrosio big D value of less than 1.6&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unstable refraction for 1 year&#xD;
&#xD;
          2. Corneal thickness less than 500 microns&#xD;
&#xD;
          3. Expected Post Lasik Residual Stromal bed less than 300 microns&#xD;
&#xD;
          4. All patients with post operative complications as epithelial overgrowth or decentered&#xD;
             ablation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasr Al Ainy</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 25, 2021</study_first_submitted>
  <study_first_submitted_qc>July 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Paula Sameh Youssef</investigator_full_name>
    <investigator_title>Resident.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

